Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Ventricular Assist Device Market: By Product By Type, By Design By Application and Region Forecast 2019 - 2023
Ventricular Assist Device Market: By Product By Type, By Design By Application and Region Forecast 2019 - 2023
Ventricular Assist Device Market size was valued at US$ 1,950.0 million in 2023 and is poised to grow at a CAGR of 8.3% from 2024-2030. The global market provides a detailed overview of the market and that can be segmented by product, type of flow, design, and application. By product, the ventricular assist device market has been segmented into left ventricular assist device, right ventricular assist device, bi-ventricular assist device, and the total artificial heart. The left ventricular assist device segment is likely to be the largest and fastest growing segment in terms of product. Based on the type of flow, the ventricular assist device market is segmented into pulsatile flow and continuous flow. Among these, the pulsatile flow segment is expected to have the fastest-growing market during the forecast period.
On the basis of design, the market is segregated into implantable ventricular assist devices and transcutaneous ventricular assist devices. The implantable ventricular assist device held a considerable market share during the forecast period. Based on application, the market is segregated into a bridge to transplant, destination therapy, and others. Bridge to transplant segment held considerable market share during the estimated period.
Study Period
2024-2030Base Year
2023CAGR
8.3%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
The pursuit of unhealthy lifestyles, rapid globalization, the aging population and the rising demand for heart transplants, the lack of organ donors and the rapid advancement of technology, as well as the demand for ventricular assist devices, all contribute to the rising incidence of chronic diseases and hence increases the demand for the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,950.0 million |
|
Market CAGR |
8.3% |
|
By Product |
|
|
By Type |
|
|
By Design |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The ventricular assist device market size was valued at US$ 1,950.0 million in 2023
The major players in the global ventricular assist device market are Abbott (US), Reliant Heart Inc. (US), Abiomed Inc. (US), Cardiac Assist Inc. (US), Cirtec (US), CorWave SA (France), Medtronic plc (Ireland), Fineheart (France) and Berlin Heart GmbH (Germany).
Asia Pacific is the fastest-growing region for ventricular assist device market
| 1. Executive Summary |
| 2. Global Ventricular Assist Device Market Introduction |
| 2.1. Global Ventricular Assist Device Market Taxonomy |
| 2.2. Global Ventricular Assist Device Market Definitions |
| 2.2.1. By Product |
| 2.2.2. By Type of Flow |
| 2.2.3. By Design |
| 2.2.4. By Application |
| 2.2.5. By Region |
| 3. Global Ventricular Assist Device Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Ventricular Assist Device Market Dynamic Factors - Impact Analysis |
| 3.6. Global Ventricular Assist Device Market Competition Landscape |
| 4. Global Ventricular Assist Device Market Analysis,2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis,2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Ventricular Assist Device Market, By Product, 2019-2023 and Forecast, 2024-2030(Revenue, USD Mn) |
| 5.1. Left Ventricular Assist Device |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Right Ventricular Assist Device |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Bi-Ventricular Assist Device |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Total Artificial Heart |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Ventricular Assist Device Market, By Type of Flow, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1. Pulsatile Flow |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Continuous Flow |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Ventricular Assist Device Market, By Design, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. Implantable Ventricular Assist Device |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Transcutaneous Ventricular Assist Device |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Ventricular Assist Device Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. Bridge to Transplant |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Destination Therapy |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Ventricular Assist Device Market Forecast, By Region, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Region, 2024-2030 |
| 10. North America Ventricular Assist Device Market Analysis,2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 10.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Left Ventricular Assist Device |
| 10.1.2. Right Ventricular Assist Device |
| 10.1.3. Bi-Ventricular Assist Device |
| 10.1.4. Total Artificial Heart |
| 10.2. Type of Flow Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Pulsatile Flow |
| 10.2.2. Continuous Flow |
| 10.3. Design Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Implantable Ventricular Assist Device |
| 10.3.2. Transcutaneous Ventricular Assist Device |
| 10.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Bridge to Transplant |
| 10.4.2. Destination Therapy |
| 10.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2024-2030 |
| 10.7. North America Ventricular Assist Device Market Dynamics Trends |
| 11. Europe Ventricular Assist Device Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 11.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Left Ventricular Assist Device |
| 11.1.2. Right Ventricular Assist Device |
| 11.1.3. Bi-Ventricular Assist Device |
| 11.1.4. Total Artificial Heart |
| 11.2. Type of Flow Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Pulsatile Flow |
| 11.2.2. Continuous Flow |
| 11.3. Design Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Implantable Ventricular Assist Device |
| 11.3.2. Transcutaneous Ventricular Assist Device |
| 11.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Bridge to Transplant |
| 11.4.2. Destination Therapy |
| 11.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 11.5. Country Analysis 2019-2023and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2024-2030 |
| 11.7. Europe Ventricular Assist Device Market Dynamics Trends |
| 12. Asia-Pacific Ventricular Assist Device Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 12.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Left Ventricular Assist Device |
| 12.1.2. Right Ventricular Assist Device |
| 12.1.3. Bi-Ventricular Assist Device |
| 12.1.4. Total Artificial Heart |
| 12.2. Type of Flow Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Pulsatile Flow |
| 12.2.2. Continuous Flow |
| 12.3. Design Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Implantable Ventricular Assist Device |
| 12.3.2. Transcutaneous Ventricular Assist Device |
| 12.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Bridge to Transplant |
| 12.4.2. Destination Therapy |
| 12.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 12.5. Country Analysis2019-2023and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country,2024-2030 |
| 12.7. Asia-PacificVentricular Assist Device Market Dynamics Trends |
| 13. Latin America Ventricular Assist Device Market Analysis,2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 13.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Left Ventricular Assist Device |
| 13.1.2. Right Ventricular Assist Device |
| 13.1.3. Bi-Ventricular Assist Device |
| 13.1.4. Total Artificial Heart |
| 13.2. Type of Flow Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Pulsatile Flow |
| 13.2.2. Continuous Flow |
| 13.3. Design Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Implantable Ventricular Assist Device |
| 13.3.2. Transcutaneous Ventricular Assist Device |
| 13.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Bridge to Transplant |
| 13.4.2. Destination Therapy |
| 13.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 13.5. Country Analysis 2019-2023and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2024-2030 |
| 13.7. Latin America Ventricular Assist Device Market Dynamics Trends |
| 14. Middle East and Africa Ventricular Assist Device Market Analysis, 2019-2023and Forecast, 2024-2030(Revenue, USD Mn) |
| 14.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Left Ventricular Assist Device |
| 14.1.2. Right Ventricular Assist Device |
| 14.1.3. Bi-Ventricular Assist Device |
| 14.1.4. Total Artificial Heart |
| 14.2. Type of Flow Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Pulsatile Flow |
| 14.2.2. Continuous Flow |
| 14.3. Design Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Implantable Ventricular Assist Device |
| 14.3.2. Transcutaneous Ventricular Assist Device |
| 14.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Bridge to Transplant |
| 14.4.2. Destination Therapy |
| 14.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others) |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Ventricular Assist Device Market - Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2024-2030 |
| 14.7. MEA Ventricular Assist Device Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, KeyOfferings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Abbott (US) |
| 15.2.2. Reliant Heart Inc. (US) |
| 15.2.3. Abiomed Inc. (US) |
| 15.2.4. Cardiac Assist Inc. (US) |
| 15.2.5. Cirtec (US) |
| 15.2.6. CorWave SA (France) |
| 15.2.7. Medtronic plc (Ireland) |
| 15.2.8. Fineheart (France) |
| 15.2.9. Berlin Heart GmbH (Germany) |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.